Cipher Pharmaceuticals Inc (CPH)

Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders

Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON, June 18, 2026...

Cipher Pharmaceuticals Reports First Quarter Results

Cipher Pharmaceuticals Reports First Quarter Results Canada NewsWire MISSISSAUGA, ON, May 7, 2026 (All figures are presented in U.S...

Cipher Pharmaceuticals Announces Normal Course Issuer Bid

Cipher Pharmaceuticals Announces Normal Course Issuer Bid Canada NewsWire MISSISSAUGA, ON, May 1, 2026 MISSISSAUGA, ON, May 1, 2026 /CNW/...

Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON, April 29, 2026 MISSISSAUGA...

Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings

Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings Canada NewsWire MISSISSAUGA, ON, March...

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON, March 4, 2026...

Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad)

Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad) Canada NewsWire...

Cipher Pharmaceuticals Reports Third Quarter 2025 Results

Cipher Pharmaceuticals Reports Third Quarter 2025 Results Canada NewsWire MISSISSAUGA, ON, Nov. 6, 2025 (All figures are presented in...

Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON, Oct. 29, 2025...

Cipher Pharmaceuticals Receives Successful Arbitration Award

Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin

Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin Canada NewsWire MISSISSAUGA, ON, Aug. 26, 2025 MISSISSAUGA, ON, Aug...

Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue

Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue Canada NewsWire MISSISSAUGA, ON, Aug. 7, 2025 (All figures...

Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON, July 29, 2025 MISSISSAUGA, ON...

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON, June 13, 2025...

Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment

Cipher Pharmaceuticals Reports First Quarter 2025 Results, and Announces $15 Million Debt Repayment Canada NewsWire MISSISSAUGA, ON, May 8, 2025...